The Measuring Patient Engagement Summit Europe is the leading industry forum dedicated to supporting biopharma in quantifying and demonstrating the true impact of patient engagement. As regulatory expectations rise and internal stakeholders demand a clearer return on investment, the need for robust, evidence-based frameworks has never been greater. This three-day summit brings together over 70 senior leaders across patient engagement, advocacy, insights, experience, and medical affairs to address one of the industry’s most pressing challenges – moving from activity-based reporting to measurable impact and defensible KPIs.

Designed to bridge the gap between strategy and proof, the event focuses on establishing credible, comparable, and actionable metrics that demonstrate how patient engagement influences decision-making across the product lifecycle. Attendees will gain practical insights into how patient input drives improvements in protocol design, accelerates clinical trial recruitment, supports regulatory alignment, and strengthens market access outcomes.

Through a combination of real-world case studies, expert-led discussions, and collaborative sessions, the summit offers a unique opportunity to benchmark approaches, co-develop frameworks, and create a shared language of value recognised by regulators, payers, and patients alike. By equipping participants with proven methodologies and peer-tested tools, the event empowers organisations to embed patient engagement as a strategic, data-driven driver of innovation – ensuring its impact is both defensible and impossible to ignore.

Agenda Highlights Include:

• Moving beyond activity-based KPIs to define and measure meaningful patient engagement impact
• Demonstrating measurable outcomes across clinical trial design, recruitment, and retention
• Quantifying the influence of patient insights on regulatory, payer, and market access decisions
• Developing credible and standardised frameworks to benchmark engagement success
• Translating patient experience data into tangible clinical and commercial value
• Aligning patient engagement strategies with ESG and broader organisational priorities
• Building a common language of value recognised across industry stakeholders

This summit provides a critical platform for advancing the measurement of patient engagement, enabling organisations to shift from intention to evidence and truly demonstrate the value of patient-centric approaches.

Get your copy of the agenda now to learn more: https://ter.li/fy580o27.